Retired Pharmacist in New Brunswick with $1.5M: RRIF Plus Home Plus Business Shares in 2026
Key Takeaways
- 1Understanding retired pharmacist in new brunswick with $1.5m: rrif plus home plus business shares in 2026 is crucial for financial success
- 2Professional guidance can save thousands in taxes and fees
- 3Early planning leads to better outcomes
- 4GTA residents have unique considerations for estate planning
- 5Taking action now prevents costly mistakes later
Quick Summary
This article covers 5 key points about key takeaways, providing essential insights for informed decision-making.
Quick Answer
A retired pharmacist dies in New Brunswick in 2026 with a $1.5M estate: $400K Fredericton home (principal residence), $500K RRIF, and $600K in pharmacy business shares with a $400K embedded capital gain (ACB $200K). New Brunswick probate is $7,500 ($5 per $1,000 flat). The RRIF collapses fully into terminal-return income — approximately $230,000 in tax at the top NB bracket. The $400K share gain triggers tiered inclusion: $250K at 50% plus $150K at 66.67%, yielding $225,000 of taxable capital gain and roughly $119,000 in tax. The home is sheltered by the principal residence exemption. Total tax-plus-probate if everything is held until death: approximately $356,500 — nearly 24% of the gross estate. A phased exit (selling the pharmacy in a low-income year and drawing down the RRIF aggressively into TFSA starting at 71) drops the combined bill by $80,000 or more.
Talk to a CFP — free 15-min call
If you hold business shares, a RRIF, and real estate in the Maritimes, the order you unwind these assets changes your estate tax bill by tens of thousands of dollars. Book a free 15-minute consultation to map out the sequence before your executor has to figure it out under deadline pressure.
The Case: A Fredericton Pharmacist with Three Very Different Asset Classes
Robert Nguyen is a retired pharmacist in Fredericton, New Brunswick. He is 69, widowed, with two adult children in Ontario. He built and ran an independent pharmacy for 32 years before stepping back from day-to-day operations three years ago. His estate breaks down into three distinct buckets — each taxed differently at death:
| Asset | Fair market value | Adjusted cost base | Embedded gain |
|---|---|---|---|
| Fredericton home (principal residence) | $400,000 | $165,000 | $235,000 (sheltered by PRE) |
| RRIF (converted from RRSP at 71) | $500,000 | n/a | $500,000 (100% taxable) |
| Pharmacy corporation shares (CCPC) | $600,000 | $200,000 | $400,000 (capital gain) |
| Total estate value | $1,500,000 | — | — |
The problem is not the probate. New Brunswick charges $5 per $1,000 on the full estate value — $7,500 on $1.5M. That is less than half of what Ontario or Nova Scotia would charge. The problem is what happens on the terminal T1 return: the RRIF and the pharmacy shares detonate at the same time, stacking roughly $725,000 of taxable income into a single tax year.
Scenario A: Hold Everything Until Death — The $356,500 Bill
If Robert makes no changes — keeps the RRIF intact, retains the pharmacy shares, dies at 82 — here is what the executor faces on the terminal return:
RRIF collapse: $500K into ordinary income
With no spouse to receive a section 146.3(6) rollover, the full $500,000 RRIF balance is added to Robert's terminal-return income. New Brunswick's top combined federal-provincial marginal rate is approximately 53%. The RRIF alone pushes Robert well past every bracket threshold. Running through the brackets, the effective federal-plus-provincial tax on $500,000 of RRIF income — after accounting for the basic personal amount and lower brackets on the first portion — comes to approximately $230,000. That is 46% of the gross RRIF value, gone to CRA in a single filing.
Pharmacy shares: $400K capital gain with tiered inclusion
Under section 70(5), Robert is deemed to have sold the pharmacy shares at fair market value immediately before death. The $400,000 capital gain hits the 2026 tiered inclusion rules:
- First $250,000 at 50% inclusion = $125,000 taxable
- Remaining $150,000 at 66.67% inclusion = $100,000 taxable
- Total taxable capital gain: $225,000
Because this income stacks on top of the $500K RRIF collapse, every dollar of the $225,000 taxable gain lands in the top combined bracket. At approximately 53%, the share gain adds roughly $119,000 in income tax to the terminal return.
The home: $0 tax (PRE applies)
The Fredericton home is Robert's only residential property. The estate designates it as the principal residence on Form T2091(IND), sheltering the full $235,000 gain under section 40(2)(b). No tax on the home.
Total bill — Scenario A
| Line item | Amount |
|---|---|
| New Brunswick probate ($5 per $1,000) | $7,500 |
| Income tax on $500K RRIF collapse | ~$230,000 |
| Capital gains tax on pharmacy shares ($400K gain, tiered) | ~$119,000 |
| Fredericton home (PRE applies) | $0 |
| Total tax + probate | ~$356,500 |
That is 24% of the gross estate consumed by tax and probate — before legal fees, executor compensation, or the accounting costs of the terminal return and estate T3. Robert's two children split approximately $1.14M, or $570,000 each, instead of $750,000.
The part most people miss: probate is $7,500. Income tax is $349,000. The RRIF collapse alone accounts for 64% of the total bill. If Robert's estate plan focuses on probate avoidance while ignoring the RRIF drawdown sequence, it is optimizing for the 2% problem and ignoring the 64% problem.
Scenario B: The Phased Exit — Sell the Pharmacy Early, Draw Down the RRIF, Use the TFSA
The phased-exit strategy has three moving parts, each targeting a different piece of the terminal-return tax stack.
Step 1: Sell the pharmacy shares while alive (control the tax year)
If Robert sells the pharmacy shares at age 70 — a year when his other income is approximately $30,000 (CPP plus OAS) — the $400,000 capital gain hits the brackets from a much lower starting point. The $225,000 of taxable capital gain (after tiered inclusion) stacks on top of $30,000 rather than on top of $500,000 of RRIF income.
At this lower starting point, the effective blended tax rate on the share gain drops from approximately 53% to roughly 37%. Tax on the shares: approximately $83,000 instead of $119,000. That is a $36,000 saving just from choosing the tax year.
Better still: if the pharmacy shares qualify as qualified small business corporation (QSBC) shares under section 110.6, Robert can claim the Lifetime Capital Gains Exemption — sheltering up to approximately $1,016,836 of lifetime capital gains in 2026. The entire $400,000 gain disappears. Tax on the shares: $0. The LCGE is available only to individuals, not to estates — meaning Robert must sell while alive to claim it. This is the single largest lever in the plan.
LCGE qualification trap: the pharmacy corporation must pass the QSBC test at the time of sale — 90% active business assets at disposition, 50%+ active throughout the prior 24 months. A retired pharmacist whose corporation holds $300K of passive investments (GICs, retained earnings parked in mutual funds) alongside $300K of pharmacy goodwill may fail the 90% test. Purification — moving passive assets out of the corporation before selling — is possible but must be planned at least 24 months before the sale to satisfy the holding-period requirement.
Step 2: Draw the RRIF aggressively starting at 71
The RRIF minimum withdrawal at age 71 is 5.28% of the January 1 balance — $26,400 on a $500K RRIF. That minimum is designed to deplete the RRIF slowly, leaving a large balance exposed to top-bracket collapse at death. Robert should consider withdrawing well above the minimum.
Drawing $50,000 to $60,000 per year from the RRIF spreads the income across lower brackets. With CPP and OAS income of approximately $30,000, a $55,000 RRIF withdrawal puts Robert's total taxable income at $85,000 — firmly in the middle brackets where the combined federal-NB rate is approximately 35%. Compare that to the 53% rate on the same dollar if it collapses at death.
Over 12 years (age 71 to 82), drawing $55,000 annually depletes roughly $660,000 from the RRIF (withdrawals plus the reduction in deferred growth). If the RRIF earns 4% annually, the balance at death drops from $500,000 to approximately $150,000 — reducing the terminal-return RRIF tax from $230,000 to approximately $70,000. The withdrawals themselves generated tax along the way, but at 35% instead of 53%.
Step 3: Redirect after-tax RRIF withdrawals into TFSA
TFSA cumulative contribution room in 2026 is $109,000 for anyone who has been eligible since 2009. Robert's after-tax RRIF withdrawals — roughly $36,000 per year after paying 35% on the $55,000 withdrawal — can fill his TFSA room over three years. Once inside the TFSA, the money grows tax-free and is not taxable at death. TFSA balances also do not count against OAS clawback (the recovery tax kicks in above $95,323 of net income in 2026).
The net effect: money that was sitting inside a RRIF (taxable at 53% on death) has been moved into a TFSA (taxable at 0% on death) — at a cost of 35% on the withdrawal. The bracket arbitrage is roughly 18 percentage points on every dollar moved.
Scenario B: Total Tax Bill After the Phased Exit
| Line item | Scenario A (hold all) | Scenario B (phased exit) |
|---|---|---|
| NB probate | $7,500 | $7,500 |
| RRIF income tax | ~$230,000 | ~$70,000 (terminal) + ~$115,000 (lifetime withdrawals) |
| Pharmacy share capital gains | ~$119,000 | ~$83,000 (no LCGE) or $0 (with LCGE) |
| Fredericton home | $0 | $0 |
| Total lifetime + terminal tax | ~$356,500 | ~$275,500 (no LCGE) or ~$192,500 (with LCGE) |
| Saving vs. Scenario A | — | $81,000 to $164,000 |
The phased exit saves between $81,000 (if the LCGE is not available) and $164,000 (if the pharmacy shares qualify for the full LCGE). Even in the worse case, the saving exceeds ten times the New Brunswick probate fee. The LCGE is the swing variable — and it is only available if Robert sells while alive and the shares pass the QSBC test at the time of sale.
The LCGE Decision: Why Selling the Pharmacy Before Death Is Almost Always Right
The Lifetime Capital Gains Exemption under section 110.6 is not available to an estate — it can only be claimed by a living individual. If Robert holds the shares until death, the $400,000 capital gain on the terminal return cannot use the LCGE. The exemption dies with him.
This is the structural reason every pharmacist, dentist, or small-business owner holding CCPC shares should plan the share disposition while alive rather than letting section 70(5) handle it. The difference between selling at age 70 (LCGE available, $0 tax on the gain) and dying at 82 (LCGE unavailable, $119,000 tax on the gain stacked on the RRIF collapse) is not a planning nuance. It is a six-figure decision.
The caveat: purifying the corporation to pass the QSBC test takes time. Passive assets must be below 10% of total FMV at the moment of sale, and the 50% active-business-asset test must hold for the 24 months before disposition. A retired pharmacist who wound down the active business three years ago and parked the retained earnings in GICs needs to restructure the balance sheet — paying out dividends to reduce passive holdings, or transferring the active business assets into a separate corporation — well before the planned sale date.
RRIF Drawdown Math: 5.28% Minimum vs. Aggressive Withdrawal
The CRA-prescribed RRIF minimum at age 71 is 5.28% of the January 1 balance. On a $500K RRIF, that is $26,400 per year — barely enough to dent the balance. At the minimum withdrawal rate, the RRIF still holds $350,000 to $400,000 at age 82, depending on investment returns. The entire remaining balance collapses into the terminal return.
The aggressive-drawdown alternative: withdraw $55,000 per year (roughly double the minimum). After 12 years, the RRIF balance at death is approximately $150,000 instead of $350,000+. The additional withdrawals were taxed at approximately 35% along the way — saving roughly 18 percentage points per dollar compared to the 53% terminal-return rate. On $200,000 of additional lifetime withdrawals (above the minimum), the bracket arbitrage produces approximately $36,000 in cumulative savings.
The OAS clawback consideration: OAS recovery tax kicks in above $95,323 of net income in 2026, at a rate of 15% on each dollar above the threshold. A $55,000 RRIF withdrawal plus $30,000 of CPP/OAS totals $85,000 — safely below the clawback threshold. Push the withdrawal to $75,000, and total income hits $105,000, triggering approximately $1,450 of OAS clawback. The trade-off is worth monitoring but not usually large enough to override the bracket arbitrage.
NB Probate Avoidance: Modest Returns, But Worth the Paperwork
New Brunswick's $5-per-$1,000 probate rate is low compared to Nova Scotia (approximately $16.95 per $1,000 above $100K) or Ontario ($15 per $1,000 above $50K). On Robert's $1.5M estate, probate is $7,500 — a fraction of the income-tax bill. Still, three probate-avoidance steps cost nothing and remove assets from the estate:
- Name RRIF beneficiaries directly: removes $500K from probate, saving $2,500. No effect on income tax.
- Name TFSA beneficiary or successor holder: removes the TFSA balance from probate. TFSA is not taxable at death regardless.
- Consider joint tenancy on the home with one child: removes the home from probate at death. But adding a child as joint tenant on real estate triggers a deemed disposition of 50% of the parent's interest at FMV — which is sheltered by the PRE on the home but would create complications if the child has creditor issues or goes through a divorce. Run the math on the specific situation.
Total probate saving from naming RRIF and TFSA beneficiaries: approximately $2,500 to $3,000. Not transformative, but free. For a broader look at how NB probate compares across the country, see our cross-Canada probate comparison.
What Robert's Children Actually Receive: Scenario A vs. Scenario B
In Scenario A (hold everything), the two children split approximately $1.14M after $356,500 in tax and probate — about $570,000 each before legal and accounting fees. In Scenario B with the LCGE available, they split approximately $1.31M — about $655,000 each. That is an $85,000 difference per child, driven entirely by the sequence and timing of asset dispositions, not by the underlying estate value.
The lesson is structural: a Maritime estate with a RRIF, business shares, and a principal residence is not one tax problem. It is three separate problems that interact on the terminal return. The RRIF pushes the shares into the top bracket. The shares push any remaining RRIF balance deeper into the top bracket. And probate sits on top of both. Planning the order of exits — shares first (for the LCGE), RRIF second (aggressively, into TFSA), probate last (named beneficiaries) — unstacks the income and drops the blended rate from 53% to 35%.
Book a free 15-minute consultation
If you are a retired business owner in the Maritimes holding CCPC shares and a RRIF, the LCGE qualification test and the RRIF drawdown sequence are the two decisions that move the needle most. Talk to our team to map out the phased exit before the section 70(5) deemed disposition does it for you at the worst possible tax rate. For more on how business sales interact with estate planning, see our business sale planning page.
Key Takeaways
- 1A $1.5M New Brunswick estate pays $7,500 in probate ($5 per $1,000 flat rate) — less than half of what Ontario or Nova Scotia would charge on the same estate, but probate is the smallest piece of the total bill
- 2The $500K RRIF collapses fully into terminal-return income with no spouse rollover available — generating approximately $230,000 in combined federal-provincial tax at the top New Brunswick bracket of roughly 53%
- 3Pharmacy shares with a $400K embedded gain trigger tiered capital gains inclusion: $250K at 50% plus $150K at 66.67%, producing $225,000 of taxable gain and approximately $119,000 in tax when stacked on top of the RRIF collapse
- 4The principal residence exemption shelters the $400K Fredericton home completely — section 40(2)(b) ITA requires the estate to file Form T2091(IND) to claim it
- 5A phased exit — selling pharmacy shares in a low-income year and drawing down the RRIF aggressively from age 71 into TFSA ($109,000 cumulative room in 2026) — reduces the combined tax-and-probate bill by over $80,000 compared to holding everything until death
Quick Summary
This article covers 5 key points about key takeaways, providing essential insights for informed decision-making.
Frequently Asked Questions
Q:How much is New Brunswick probate on a $1.5M estate in 2026?
A:New Brunswick charges $5 per $1,000 on the full estate value with no tiered threshold — every dollar from the first to the last is assessed at the same flat rate. On a $1.5M estate, that works out to $7,500 ($1,500 × $5). That is significantly less than Ontario ($21,750 on the same estate) or Nova Scotia (roughly $23,700 at their top-of-Canada 1.695% marginal rate above $100K), but more than Alberta ($525 capped) or Manitoba ($0). New Brunswick's flat-rate structure means probate scales linearly — $5,000 on $1M, $10,000 on $2M — with no breakpoints or caps.
Q:What happens to a $500K RRIF when the pharmacist dies with no spouse?
A:The full $500,000 RRIF balance is deemed received as income on the deceased's terminal T1 return under section 146.3(6) of the Income Tax Act. Without a spouse, common-law partner, or financially dependent child or grandchild to receive a tax-deferred rollover, the entire balance collapses into ordinary income in a single tax year. In New Brunswick, the top combined federal-provincial marginal rate is approximately 53%, and a $500K RRIF collapse pushes the deceased well past the top bracket threshold. The effective tax on the RRIF alone — after running through all the federal and provincial brackets — lands in the range of $220,000 to $240,000. This is the single largest line item on the terminal return, dwarfing both probate and the capital gains bill on the pharmacy shares.
Q:How are pharmacy business shares taxed at death under section 70(5)?
A:Under section 70(5) of the Income Tax Act, the pharmacist is deemed to have disposed of the pharmacy shares at fair market value immediately before death. With $600,000 FMV and $200,000 adjusted cost base, that triggers a $400,000 capital gain. The 2026 tiered inclusion rules apply: the first $250,000 of annual capital gains is included at 50% ($125,000 taxable), and the remaining $150,000 above the threshold is included at 66.67% ($100,000 taxable). Total taxable capital gain: $225,000. At the top New Brunswick combined rate of approximately 53%, this generates roughly $119,000 in income tax — stacked on top of the RRIF collapse on the same terminal return.
Q:Does the $400K home qualify for the principal residence exemption?
A:Yes. The pharmacist's Fredericton home qualifies for the principal residence exemption under section 40(2)(b) of the Income Tax Act, provided the estate designates it on Form T2091(IND) with the terminal return. Since the pharmacist owns only one residential property (the pharmacy shares are business property, not real estate), the PRE designation is straightforward — every year of ownership can be allocated to the home, sheltering the entire gain. The home's appreciation from its adjusted cost base to the $400,000 fair market value is fully exempt. The PRE does not reduce probate, however — the home's $400,000 FMV is still included in the estate value for New Brunswick's $5-per-$1,000 probate calculation.
Q:Can the pharmacist use the Lifetime Capital Gains Exemption on the pharmacy shares?
A:Only if the pharmacy shares qualify as shares of a qualified small business corporation (QSBC) under section 110.6 of the Income Tax Act. The QSBC test requires that at least 90% of the corporation's assets at the time of sale are used in an active business carried on primarily in Canada, and that more than 50% of assets were used in active business throughout the preceding 24 months. A retired pharmacist who has already ceased active operations or whose corporation holds significant passive investments (retained earnings sitting in GICs, for example) may fail this test. If the shares do qualify, the LCGE shelters up to approximately $1,016,836 of capital gains in 2026 — more than enough to cover the $400,000 embedded gain. The LCGE is a lifetime limit, not per-year, so any prior claims reduce the available room.
Q:Why draw down the RRIF aggressively before death instead of letting it grow?
A:Because the terminal-return tax rate on a $500K RRIF collapse is approximately 53% in New Brunswick — the top combined marginal rate. Drawing $40,000 to $60,000 per year starting at age 71 spreads the income across lower brackets (approximately 30–38% combined marginal rates in the middle brackets) instead of concentrating it in the top bracket at death. The trade-off: you lose tax-deferred compounding inside the RRIF. But for a retiree with no spouse to receive a tax-deferred rollover, the bracket arbitrage almost always wins. Redirecting the after-tax RRIF withdrawals into TFSA (up to $109,000 cumulative room in 2026) shelters future growth permanently — TFSA balances are not taxable at death and do not count against income-tested benefits like OAS.
Q:How much does selling the pharmacy before death save in taxes?
A:Selling the pharmacy shares in a year when the pharmacist has low other income — say, $30,000 of CPP/OAS and minimal RRIF withdrawals — means the $400,000 capital gain hits the brackets from a much lower starting point. The taxable capital gain ($225,000 after tiered inclusion) is taxed starting from the bottom of the bracket schedule rather than being stacked on top of a $500,000 RRIF collapse. The saving depends on timing: if the pharmacist sells in a year with $30,000 of other income, the effective tax rate on the share gain is approximately 35–40% (blended across brackets), versus approximately 53% when stacked on the terminal return. On $225,000 of taxable gain, that bracket difference saves roughly $30,000 to $40,000 in income tax. Plus, if the shares qualify for the LCGE, the entire $400,000 gain could be sheltered — saving the full $119,000.
Q:Should the pharmacist name RRIF beneficiaries directly or leave it to the estate?
A:Naming the children as direct RRIF beneficiaries removes the $500,000 from the probate calculation, saving $2,500 in New Brunswick probate ($500,000 × $5 per $1,000). The income tax on the RRIF collapse is unchanged — CRA still attributes the full balance to the deceased's terminal return regardless of whether the RRIF passes through the estate or directly to named beneficiaries. So this is a probate-only saving. The named-beneficiary route also speeds up the transfer (no waiting for the probate grant) and avoids the risk of estate creditors reaching the RRIF proceeds. There is no downside to naming beneficiaries on the RRIF unless the estate needs the RRIF cash to pay the terminal-return tax bill — in which case the executor may need to recover funds from the beneficiaries under section 160 of the ITA.
Question: How much is New Brunswick probate on a $1.5M estate in 2026?
Answer: New Brunswick charges $5 per $1,000 on the full estate value with no tiered threshold — every dollar from the first to the last is assessed at the same flat rate. On a $1.5M estate, that works out to $7,500 ($1,500 × $5). That is significantly less than Ontario ($21,750 on the same estate) or Nova Scotia (roughly $23,700 at their top-of-Canada 1.695% marginal rate above $100K), but more than Alberta ($525 capped) or Manitoba ($0). New Brunswick's flat-rate structure means probate scales linearly — $5,000 on $1M, $10,000 on $2M — with no breakpoints or caps.
Question: What happens to a $500K RRIF when the pharmacist dies with no spouse?
Answer: The full $500,000 RRIF balance is deemed received as income on the deceased's terminal T1 return under section 146.3(6) of the Income Tax Act. Without a spouse, common-law partner, or financially dependent child or grandchild to receive a tax-deferred rollover, the entire balance collapses into ordinary income in a single tax year. In New Brunswick, the top combined federal-provincial marginal rate is approximately 53%, and a $500K RRIF collapse pushes the deceased well past the top bracket threshold. The effective tax on the RRIF alone — after running through all the federal and provincial brackets — lands in the range of $220,000 to $240,000. This is the single largest line item on the terminal return, dwarfing both probate and the capital gains bill on the pharmacy shares.
Question: How are pharmacy business shares taxed at death under section 70(5)?
Answer: Under section 70(5) of the Income Tax Act, the pharmacist is deemed to have disposed of the pharmacy shares at fair market value immediately before death. With $600,000 FMV and $200,000 adjusted cost base, that triggers a $400,000 capital gain. The 2026 tiered inclusion rules apply: the first $250,000 of annual capital gains is included at 50% ($125,000 taxable), and the remaining $150,000 above the threshold is included at 66.67% ($100,000 taxable). Total taxable capital gain: $225,000. At the top New Brunswick combined rate of approximately 53%, this generates roughly $119,000 in income tax — stacked on top of the RRIF collapse on the same terminal return.
Question: Does the $400K home qualify for the principal residence exemption?
Answer: Yes. The pharmacist's Fredericton home qualifies for the principal residence exemption under section 40(2)(b) of the Income Tax Act, provided the estate designates it on Form T2091(IND) with the terminal return. Since the pharmacist owns only one residential property (the pharmacy shares are business property, not real estate), the PRE designation is straightforward — every year of ownership can be allocated to the home, sheltering the entire gain. The home's appreciation from its adjusted cost base to the $400,000 fair market value is fully exempt. The PRE does not reduce probate, however — the home's $400,000 FMV is still included in the estate value for New Brunswick's $5-per-$1,000 probate calculation.
Question: Can the pharmacist use the Lifetime Capital Gains Exemption on the pharmacy shares?
Answer: Only if the pharmacy shares qualify as shares of a qualified small business corporation (QSBC) under section 110.6 of the Income Tax Act. The QSBC test requires that at least 90% of the corporation's assets at the time of sale are used in an active business carried on primarily in Canada, and that more than 50% of assets were used in active business throughout the preceding 24 months. A retired pharmacist who has already ceased active operations or whose corporation holds significant passive investments (retained earnings sitting in GICs, for example) may fail this test. If the shares do qualify, the LCGE shelters up to approximately $1,016,836 of capital gains in 2026 — more than enough to cover the $400,000 embedded gain. The LCGE is a lifetime limit, not per-year, so any prior claims reduce the available room.
Question: Why draw down the RRIF aggressively before death instead of letting it grow?
Answer: Because the terminal-return tax rate on a $500K RRIF collapse is approximately 53% in New Brunswick — the top combined marginal rate. Drawing $40,000 to $60,000 per year starting at age 71 spreads the income across lower brackets (approximately 30–38% combined marginal rates in the middle brackets) instead of concentrating it in the top bracket at death. The trade-off: you lose tax-deferred compounding inside the RRIF. But for a retiree with no spouse to receive a tax-deferred rollover, the bracket arbitrage almost always wins. Redirecting the after-tax RRIF withdrawals into TFSA (up to $109,000 cumulative room in 2026) shelters future growth permanently — TFSA balances are not taxable at death and do not count against income-tested benefits like OAS.
Question: How much does selling the pharmacy before death save in taxes?
Answer: Selling the pharmacy shares in a year when the pharmacist has low other income — say, $30,000 of CPP/OAS and minimal RRIF withdrawals — means the $400,000 capital gain hits the brackets from a much lower starting point. The taxable capital gain ($225,000 after tiered inclusion) is taxed starting from the bottom of the bracket schedule rather than being stacked on top of a $500,000 RRIF collapse. The saving depends on timing: if the pharmacist sells in a year with $30,000 of other income, the effective tax rate on the share gain is approximately 35–40% (blended across brackets), versus approximately 53% when stacked on the terminal return. On $225,000 of taxable gain, that bracket difference saves roughly $30,000 to $40,000 in income tax. Plus, if the shares qualify for the LCGE, the entire $400,000 gain could be sheltered — saving the full $119,000.
Question: Should the pharmacist name RRIF beneficiaries directly or leave it to the estate?
Answer: Naming the children as direct RRIF beneficiaries removes the $500,000 from the probate calculation, saving $2,500 in New Brunswick probate ($500,000 × $5 per $1,000). The income tax on the RRIF collapse is unchanged — CRA still attributes the full balance to the deceased's terminal return regardless of whether the RRIF passes through the estate or directly to named beneficiaries. So this is a probate-only saving. The named-beneficiary route also speeds up the transfer (no waiting for the probate grant) and avoids the risk of estate creditors reaching the RRIF proceeds. There is no downside to naming beneficiaries on the RRIF unless the estate needs the RRIF cash to pay the terminal-return tax bill — in which case the executor may need to recover funds from the beneficiaries under section 160 of the ITA.
Ready to Take Control of Your Financial Future?
Get personalized estate planning advice from Toronto's trusted financial advisors.
Schedule Your Free Consultation